Outcomes
OmniSeq Received a Strategic Investment from HITACHI April 12, 2018
Crosstree Capital Partners acted as exclusive financial advisor to OmniSeq.
Outcomes
MedLabs Diagnostics Recapitalized by Caymus Equity and PNC Mezzanine Capital April 3, 2018
Crosstree Capital Partners acted as exclusive financial advisor to MedLabs Diagnostics.
Outcomes
Trevigen acquired by Bio-Techne September 5, 2017
Crosstree Capital Partners acted as exclusive financial advisor to Trevigen.